Skip to main content
NewslettersWatchlist

Sangamo Therapeutics(SGMO-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Sangamo Therapeutics Announces Fourth Quarter and Full Year 2022 Conference Call and Webcast

Business Wire - Tue Feb 21, 2023

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company is scheduled to hold a conference call on Wednesday, February 22, 2023 at 4:30 p.m. ET to review its fourth quarter and full year 2022 financial results and business updates. Prior to the call, the company will have released its fourth quarter and full year financial results.

Participants should register for, and access, the call using this link. While not required, it is recommended to join 10 minutes prior to the event start. Once registered, participants will be given the option to either dial into the call with the number and unique passcode provided, or to use the dial-out option to connect their phone instantly. The link to access the live webcast can also be found on the Sangamo Therapeutics website in the Investors and Media section under Events.

An updated corporate presentation will be available in the Investors and Media section under Presentations.

A replay will be available following the conference call, accessible under Events.

About Sangamo Therapeutics

Sangamo Therapeutics is a clinical-stage biopharmaceutical company with a robust genomic medicines pipeline. Using ground-breaking science, including our proprietary zinc finger genome engineering technology and manufacturing expertise, Sangamo aims to create new genomic medicines for patients suffering from diseases for which existing treatment options are inadequate or currently don’t exist. To learn more, visit www.sangamo.com and connect with us on LinkedIn and Twitter.

Provided Content: Content provided by Business Wire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

globe investor
Hoka-owner Deckers’ shares breach $1,000 mark for the first time
Dr. Richard Ehrlich puts on his Hoka Stinson ATR trail running shoes in Caledon, Ontario, on Tuesday, December 23, 2014.
inside the market
Short sales on the TSX: What bearish investors are betting against
Larry MacDonald
inside the market
Reminder: The Globe Investing Club wants your stock picks
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 26.
market news
The close: Stocks rebound amid encouraging U.S. economic data
Traders work on the floor of the New York Stock Exchange during morning trading on May 17.
inside the market
What every Canadian investor needs to know today
Traders work on the floor of the New York Stock Exchange during morning trading on May 17, 2024 in New York City. Wall Street stocks opened little changed May 17 after pulling back from a record run where the Dow exceeded 40,000 points for the first time. Around 10 minutes into trading the Dow Jones Industrial Average was steady at 39,872.66. (Photo by ANGELA WEISS / AFP) (Photo by ANGELA WEISS/AFP via Getty Images)
investment ideas
Bullish on Canadian National Railway Co.
Monica Rizk
globe investor
Nvidia’s split of soaring stock could boost retail investor appeal, Dow chances
A view of a Nvidia logo at their headquarters in Taipei, Taiwan May 31, 2023.
market news
The close: Stocks fall despite Nvidia boost as U.S. inflation concerns weigh; Dow sees worst drop since March 2023 on Boeing woes
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 16.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).